中枢神经细胞瘤的两种术式比较与术后并发症

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (708 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the different surgical results of removing central neurocytomas by different operation methods, and discuss the postoperative complications. Methods 87 patients with central neurocytoma admitted to this hospital between September 2012 and August 2014 were enrolled and divided into two groups according to different surgical approaches. Group 1 (27 cases) underwent operation by interhemispheric transcallosal approach, while group 2 (60 cases) had their tumors removed through cortex colostomy. Preoperative symptoms, removal rate and postoperative complications in the two groups were retrospectively analyzed. Results The total removal rates were 26% (7 cases) and 30% (18 cases) in group 1 and group 2, respectively. In group 1, decline of muscle strength occurred in 3 cases (11.1%), and epilepsy in 1 case (3.7%); in group 2, decline of muscle strength and epilepsy both occurred in 9 cases (15.0%). Conclusions Both methods are primary treatment choice for central neurocytoma with good prognosis. But decline in muscle strength and epilepsy are more likely to occur when the tumors are removed through cortex colostomy than by interhemispheric transcrallosal approach.

Key words： central neuroytoma surgical approach post-operative complications

Received: 11 November 2014

ZTFLH:

R739.91

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Yan
	LI Dongmei
	YU Shuqing
	CHEN Siyuan
	YU Tao
	QIAN Ke

Cite this article:

LI Yan,LI Dongmei,YU Shuqing等. Research of surgical approach to Central neurocytomas and postoperative complications[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2015, 26(4): 379-382.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2015/V26/I4/379

[1]	李昱,叶秀峰,李伟,等. 15例中枢神经细胞瘤的临床病理分析[J]. 重庆医科大学学报,2010,35(15):1101-1104.
[2]	陈洁,王健,王莹,等. 24例中枢神经细胞瘤的临床病理特点及免疫组化分析[J].医学信息,2014,27(12):131-132.
[3]	Barani I J, Raleigh D R, Larson D. The management of central neurocytoma: radiotherapy[J]. Neurosurg Clin N Am,2014,26(1):45-56.
[4]	Stapleton C J, Walcott B P, Kahle K T, et al. Diffuse central neurocytoma with craniospinal dissemination[J]. J Clin Neurosci,2012,19(1):163-166.
[5]	Li Y, Ye X F, Qian G, et al. Pathologic features and clinical outcome of central neurocytoma: analysis of 15 cases[J]. Chin J Cancer Res,2012,24(4):284-290.
[6]	Apuzzo M L, Chikovani O K, Gott P S, et al. Transcallosal, interfornicial approaches for lesions affecting the third ventricle: surgical considerations and consequences[J]. Neurosurgery, 1982,24(10):547-554.
[7]	Ulm A J, Russo A, Albanese E, et al. Limitations of the transcallosal transchoroidal approach to the third ventricle[J]. Neurosurgery ,2009,111(6):600-609.
[8]	Loftus C M,Copeland B. Seizures during the immediate postoperative period[J].Neurosurgery,1983:12(1)14-17.
[9]	钱海鹏,林松,曹勇,等.中枢神经细胞瘤94例临床分析[J].中华神经外科杂志,2011,27(2):10-12.
[10]	于书卿,赵继宗.中枢神经细胞瘤17例临床分析[J].中国肿瘤临床,2002,29(3):208-210.
[11]	Vndon P N ,Mahapata A K,Khosla A.Epilieptic seizures in supratentorial gliomas[J]. Neurol India, 2001,49(1):55-59.
[12]	Piepmeier J M,Spencer D D, Sass K J,et al.Lateral ventricular masses apuzzomlg brain surgery:complication avoidance management[J].New York: Churchill LI Ving stone,1993,15(8):581-600.
[13]	Kim C Y, Kim D G, Joo J D,Kim Y H.Clinical outcome and quality of life after treatment of patients with central neurocytoma[J].Neurosurg Clin N Am, 2015,26(1):83-90.